1 1

Bejescin(Obinutuzumab) Бейджесцин (обинутузумаб)

Bejescin(Obinutuzumab) Бейджесцин (обинутузумаб)

Brand Name: Bejescin
Small Orders: Subject to supplier availability
Tags: #Bejescin #Obinutuzumab #MonoclonalAntibody #Antineoplastic #Oncology #CancerTreatment #BloodCancer #CLL #ChronicLymphocyticLeukemia #FollicularLymphoma #BCellLymphoma #Immunotherapy #TargetedTherapy #IVInfusion #PrescriptionMedicine
View full details
  • Details
  • Description
Packaging Size: Typically 1 vial; verify the specific product
Strength: Obinutuzumab 1,000 mg/40 mL (25 mg/mL) — verify the specific presentation
Composition: Obinutuzumab
Treatment: Used in oncology for certain B-cell malignancies, including chronic lymphocytic leukemia (CLL) and follicular lymphoma, according to the applicable treatment regimen.
Brand: Bejescin
Quantity Unit: Vial

Bejescin (obinutuzumab) is an antineoplastic medicine containing obinutuzumab as its active ingredient. It is a monoclonal antibody that targets the CD20 protein found on the surface of B lymphocytes.

Indications: Obinutuzumab is used as part of specific treatment regimens for certain B-cell blood cancers, including chronic lymphocytic leukemia (CLL) and follicular lymphoma. Approved indications may vary depending on the country and the specific product labeling.

Dosage form: The medicine is generally supplied as a concentrate for preparation of a solution for intravenous infusion.

Administration: It is administered intravenously by a healthcare professional. The dosage and treatment schedule depend on the disease and the treatment regimen prescribed by the physician.

Everyone Deserves Access to Life-saving Treatment Of Cancer. We are a Trusted Cancer Medicine seller delivering certified medications to every corner of the world.